Statement of the American Society of Clinical Oncology: Genetic Testing for Cancer Susceptibility

Journal of Clinical Oncology

Volumn 14, Issue 5, 1996, Pages 1730-1736

  Beckhardt, Stacy ^a  

^a AMERICAN SOCIETY OF CLINICAL ONCOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RISK; CANCER SUSCEPTIBILITY; CLINICAL RESEARCH; EMPLOYER; FAMILIAL CANCER; FAMILY HISTORY; GENETIC ANALYSIS; GENETIC COUNSELING; HEALTH INSURANCE; HUMAN; INFORMED CONSENT; LAW; MEDICAL EDUCATION; MEDICAL SOCIETY; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; REVIEW;

AMERICAN SOCIETY OF CLINICAL ONCOLOGY; BREAST CANCER; CANCER; CLINICAL APPROACH/SOURCE; FAMILY MEMBERS; GENETIC RESEARCH; GENETIC SERVICES; GENETICS AND REPRODUCTION; GOVERNMENT REGULATION; PROFESSIONAL ORGANIZATIONS; REGULATION; RISKS AND BENEFITS; SELECTION FOR TREATMENT; SOCIAL DISCRIMINATION;

DISCLOSURE; DISEASE SUSCEPTIBILITY; GENETIC COUNSELING; GENETIC RESEARCH; GENETIC SCREENING; GENETIC SERVICES; GOVERNMENT REGULATION; HUMANS; MEDICAL ONCOLOGY; NEOPLASMS; PATIENT SELECTION; PHYSICIAN'S ROLE; RISK ASSESSMENT; SOCIAL CONTROL, FORMAL; SOCIETIES, MEDICAL; UNITED STATES;

EID: 0029864134     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/jco.1996.14.5.1730     Document Type: Article

References (15)

1. National Advisory Council for Human Genome Research: Statement on use of DNA testing for presymptomatic identification of cancer risk. JAMA 271:785, 1994
2. Statement of The American Society of Human Genetics on genetic testing for breast and ovarian cancer predisposition. Am J Hum Genet 55:i-iv, 1994
3. Marra G, Boland CR: Hereditary nonpolyposis colorectal cancer: The syndrome, the genes, and historical perspective. J Natl Cancer Inst 87:1114-1125, 1995
4. Nystrom-Lahti M, Parsons R, Sistonen P, et al: Mismatch repair genes on chromosome 2p and 3p account for a major share of hereditary nonpolyposis colorectal cancer families evaluable by linkage. Am J Hum Genet 55:659-665, 1994
5. Shattuck-Eidens D, McClure M, Simar J, et al: A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene. Implications for presymptomatic testing and screening. JAMA 273:535-541, 1995
6. Hoskins KF, Stopfer JE, Calzone KA, et al: Assessment and counseling for women with a family history of breast cancer. JAMA 273:577-585, 1995
7. FitzGerald MG, MacDonald DJ, Krainer M, et al: Germ-line BRCA1 mutations in Jewish and non-Jewish women with early onset breast cancer. N Engl J Med 334:143-149, 1996
8. Wooster R, Bignell G, Lancaster J, et al: Identification of the breast cancer gene BRCA2. Nature 378:789-791, 1995
9. Wells SA, Chi DD, Toshima K, et al: Predictive DNA testing and prophylactic thyroidectomy in patients at risk for multiple endocrine neoplasia type 2A. Ann Surgery 220:237-250, 1994
10. Wiggs J, Nordenskjold M, Yandell D, et al: Prediction of the risk of hereditary retinoblastoma, using DNA polymorphisms within the retinoblastoma gene. New Engl J Med 318:151-157, 1988
11. Powell S, Petersen G, Krush AJ, et al: Molecular diagnosis of familial adenomatous polyposis. New Engl J Med 329:1982-1987, 1993
12. Whelan AJ, Bartsch D, Goodfellow PJ: A familial syndrome of pancreatic cancer and melanoma with a mutation in the CDKN2 tumor suppressor gene. New Engl J Med 333:975-977, 1995
13. Offit K, Brown K: Quantitating familial cancer risk: A resource for clinical oncologists. J Clin Oncol 12:1724-1736, 1994
14. Earley CL, Strong LC: Certificates of confidentiality: A valuable tool for protecting genetic data. Am J Hum Genet 57:727-731, 1995
15. American College of Medical Genetics: Standards and Guidelines: Clinical Laboratory Genetics. Bethesda, MD, American College of Medical Genetics, 1993